Preventing Surgery-Induced NK Cell Dysfunction Using Anti-TGF-β Immunotherapeutics
Authors:
- Marisa MarketMMMarisa Market
- Gayashan TennakoonGTGayashan Tennakoon
- Marlena ScaffidiMSMarlena Scaffidi
- David P. CookDCDavid P. Cook
- Leonard AngkaLALeonard Angka
- Juliana NgJNJuliana Ng
- Christiano Tanese de SouzaCSChristiano Tanese de Souza
- Michael A. KennedyMKMichael A. Kennedy
- Barbara C. VanderhydenBVBarbara C. Vanderhyden
- Rebecca C. AuerRARebecca C. Auer
Open Access
- 23 November 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (23) , 14608
Abstract
Natural Killer (NK) cell cytotoxicity and interferon-gamma (IFNγ) production are profoundly suppressed postoperatively. This dysfunction is associated with increased morbidity and cancer recurrence. NK activity depends on the integration of activating and inhibitory signals, which may be modulated by transforming growth factor-beta (TGF-β). We hypothesized that impaired postoperative NK cell IFNγ production is due to altered signaling pathways caused by postoperative TGF-β. NK cell receptor expression, downstream phosphorylated targets, and IFNγ production were assessed using peripheral blood mononuclear cells (PBMCs) from patients undergoing cancer surgery. Healthy NK cells were incubated in the presence of healthy/baseline/postoperative day (POD) 1 plasma and in the presence/absence of a TGF-β-blocking monoclonal antibody (mAb) or the small molecule inhibitor (smi) SB525334. Single-cell RNA sequencing (scRNA-seq) was performed on PBMCs from six patients with colorectal cancer having surgery at baseline/on POD1. Intracellular IFNγ, activating receptors (CD132, CD212, NKG2D, DNAM-1), and downstream target (STAT5, STAT4, p38 MAPK, S6) phosphorylation were significantly reduced on POD1. Furthermore, this dysfunction was phenocopied in healthy NK cells through incubation with rTGF-β1 or POD1 plasma and was prevented by the addition of anti-TGF-β immunotherapeutics (anti-TGF-β mAb or TGF-βR smi). Targeted gene analysis revealed significant decreases in S6 and FKBP12, an increase in Shp-2, and a reduction in NK metabolism-associated transcripts on POD1. pSmad2/3 was increased and pS6 was reduced in response to rTGF-β1 on POD1, changes that were prevented by anti-TGF-β immunotherapeutics. Together, these results suggest that both canonical and mTOR pathways downstream of TGF-β mediate phenotypic changes that result in postoperative NK cell dysfunction.Keywords
Funding Information
- Terry Fox Foundation (1073)
- Canadian Institutes of Health Research, Canadian Cancer Society (1073)
- University of Ottawa (1073)
This publication has 98 references indexed in Scilit:
- Critical Role of Transforming Growth Factor Beta in Different Phases of Wound HealingAdvances in Wound Care, 2013
- Targeting TGF-β signaling in cancerExpert Opinion on Therapeutic Targets, 2013
- TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV PersistencePLOS Pathogens, 2012
- The Two Faces of Interferon-γ in CancerClinical Cancer Research, 2011
- Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1Blood, 2011
- Assessment of the Evolution of Cancer Treatment TherapiesCancers, 2011
- Improving Postoperative Immune Status and Resistance to Cancer MetastasisAnnals of Surgery, 2011
- In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-β1Blood, 2008
- Perioperative Use of β-blockers and COX-2 Inhibitors May Improve Immune Competence and Reduce the Risk of Tumor MetastasisAnnals of Surgical Oncology, 2008
- IL-2– and IL-15–induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytesBlood, 2008